Perrigo Company To Acquire Elan Corporation, PLC for US$8.6 Billion, Establishing Premier Global Healthcare Company
- Establishes a differentiated platform for further international expansion
- Strengthens business and financial profile with highly diversified revenue streams and enhanced cash flows
- Creates a combined entity with industry-leading revenue, adjusted EBITDA and earnings growth rates
- Immediately accretive to Perrigo's adjusted earnings per share in 2014
- Creates opportunity for substantial after-tax annual operating expense and tax savings of more than US$150 million
- Elan shareholders to receive US$6.25 in cash and 0.07636 shares of New Perrigo for each Elan share, valuing each Elan share at US$16.50 based on the closing price per Perrigo share on 26 July 2013
Jul 29, 2013
For further information: Arthur J. Shannon, Vice President, Investor Relations and Communication, (269) 686-1709, E-mail: [email protected], Bradley Joseph, Senior Manager, Investor Relations and Communication, (269) 686-3373, E-mail: [email protected]